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Unlike most cell types examined, nonpermissive Chinese hamster ovary (CHO) cells readily underwent apoptosis upon
infection with vaccinia virus (VV). Apoptosis was observed as early as 3 h postinfection with an electrophoretic assay of DNA
fragmentation and by 8 h using an in situ (TUNEL) assay. The CHO hr gene from cowpox virus, which overcomes host range
restriction of VV in CHO cells, merely delayed the onset of apoptosis by approximately 3 h. Intermediate and late viral protein
synthesis were not necessary for apoptosis since these events do not proceed under nonpermissive conditions. Apoptosis
also occurred in the presence of cytosine arabinoside or cycloheximide, which inhibits DNA or protein synthesis, respec-
tively, and after infection with a mutant virus that is blocked in early transcription. We also demonstrated that viral early
transcription was not required for induction of apoptosis by infecting CHO cells with psoralen/UV-inactivated virus. On the
other hand, apoptosis was inhibited by a neutralizing antibody to the virion L1R protein added either before or after virus
attachment to cells. These results indicate that a postbinding step associated with cell entry is sufficient and required for
induction of apoptosis in CHO cells. Recent progress on apoptotic signaling pathways raises the possibility that a cellular
receptor for VV may be involved in apoptosis.
INTRODUCTION
Apoptotic cell death is executed by a genetic program
that is activated by developmental and environmental
cues (reviewed in Mihich and Schimke, 1994; White,
1996). The occurrence of apoptosis in virus-infected cells
is a long-standing observation; chromosomal abnormal-
ities, DNA strand breaks, and pyknotic nuclei were all
included in early descriptions of cytopathic effects. A
more recent discovery, that a variety of viruses have
acquired or evolved a formidable battery of antiapoptotic
genes, is testament to the central role of apoptosis in the
host antiviral response (reviewed in Razvi and Welsh,
1995; Shen and Shenk, 1995; Gillet and Brun, 1996).
A significant portion of the large DNA genomes of
poxviruses encodes proteins whose function is to thwart
or delay the host immune response. Examples include a
variety of secreted proteins, including homologs of reg-
ulators of complement activation, the tumor necrosis
factor receptor (TNFR), the interleukin-1b receptor, and
the g-interferon receptor, as well as intracellular proteins
that block the antiviral effects of interferons (reviewed in
Alcami and Smith, 1995; McFadden, 1995; Moss, 1996).
One such protein, the cowpox virus cytokine response
modifier crmA, originally identified as a serine protease
inhibitor (serpin) that inactivates the interleukin-1b con-
verting enzyme (ICE) (Ray et al., 1992; Komiyama et al.,
1994), was subsequently shown to block Fas- and tumor
necrosis factor (TNF)-induced apoptosis (Tewari and
Dixit, 1995; Tewari et al., 1995; Enari et al., 1995), as well
as apoptosis induced via the newly identified apo-3 re-
ceptor, a member of the TNFR superfamily (Marsters et
al., 1996). Similar activities have been identified for crmA
homologs, SPI-2 of vaccinia virus (VV) (Dobbelstein and
Shenk, 1996) and rabbitpox (Brooks et al., 1995; Taka-
hashi et al., 1996), and serp2 of myxoma virus (Petit et al.,
1996). The myxoma virus M-T2 gene encodes two distinct
activities, a secreted TNFR homolog that binds and in-
hibits TNF-a and another that acts intracellularly to in-
hibit apoptosis (Macen et al., 1996; McFadden et al.,
1997; Schreiber et al., 1997). Recent work has revealed
that the molluscum contagiosum virus MC159 gene,
which encodes a protein with sequence similarity to
death effector domains of the Fas/TNFR signaling path-
way, protects cells from Fas- and TNFR-mediated apop-
tosis (Bertin et al., 1997; Hu et al., 1997; Thome et al.,
1997). Another molluscum contagiosum gene product, a
selenoprotein, prevents ultraviolet (UV)- and hydrogen
peroxide-mediated cell death (Shisler et al., 1998).
Roles for antiapoptotic poxvirus proteins in overcom-
ing host range restriction have been demonstrated. The
rabbitpox SPI-1 gene is required for productive infection
and prevention of apoptosis in pig kidney (PK15) or hu-
man (A549) cells (Brooks et al., 1995). The VV E3L gene
is required for productive infection of HeLa and Vero
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cells, and mutants that lack the gene are interferon-
sensitive and induce apoptosis in HeLa cells (Beattie et
al., 1991, 1996; Chang et al., 1995a). The myxoma virus
M-T2 gene is required for productive infection of a CD41
T lymphoma line; in the absence of M-T2 these cells
undergo apoptosis (Macen et al., 1996). Similarly, the
myxoma virus M-T5 gene is required for virus growth and
inhibition of apoptosis in a rabbit T lymphocyte line
(Mossman et al., 1996). Of direct relevance to the present
study, the cowpox virus CHO hr gene delays apoptosis in
nonpermissive Chinese hamster ovary (CHO) cells (Ink
et al., 1995). The adenovirus E1B-19K gene can substitute
for CHO hr and prevent apoptosis, but does not relieve
VV host range restriction in CHO cells, suggesting an
additional block to virus replication.
While considerable attention has been directed to-
ward poxviral antiapoptotic genes, little is known regard-
ing how poxviruses induce apoptosis. We examined the
requirements for induction of apoptosis by VV in CHO
cells. The results indicate that viral gene expression is
not required and that virion binding and entry are suffi-
cient.
RESULTS
Nonpermissive Chinese hamster ovary cells undergo
vaccinia virus-induced apoptosis
During previous studies of VV host range restriction,
we noted that the viabilities of RK13 and CHO cells were
inversely related to viral replication (Ramsey-Ewing and
Moss, 1996). Thus, more than two-thirds of the produc-
tively infected cells stained with trypan blue, indicative of
a loss of membrane integrity associated with cell death,
compared to less than one-third of abortively infected
cells.
To determine if apoptosis was the cause of the cell
death observed during productive infection, we em-
ployed a DNA fragmentation assay that assesses nu-
cleosomal cleavage, a hallmark of apoptosis. CHO, BS-
C-1, or RK13 cells, in which genomic DNA had been
radiolabeled with [125I]deoxyuridine, were infected with
various VV host range mutants (vK1L1CP772, vK1L1CP771,
vK1L2CP772, and vK1L2CP771) at multiplicities of 30
plaque-forming units (PFU)/cell (Fig. 1). Only those vi-
ruses that contain the CHO hr (CP77) gene can produc-
tively infect CHO cells, whereas those that contain either
K1L or CP77 can replicate in RK13 cells. BS-C-1 cells
failed to undergo apoptosis when infected with any of the
viruses under conditions in which greater than 90% of the
cells were nonviable. In RK13 cells, slight degradation of
DNA was noted under permissive or nonpermissive con-
ditions. In contrast, substantial apoptosis occurred when
CHO cells were infected with all of the viruses, regard-
less of whether they carried the CHO hr gene.
We performed a similar analysis on additional cell
lines that varied in their abilities to support VV growth
(Table 1). Monolayer cultures were infected for 24 h with
either 30 or 0.5 PFU/cell of wild-type VV for analysis of
nucleosomal laddering or virus growth, respectively. De-
spite the fact that the panel included nonpermissive,
semipermissive, and permissive cell lines, apoptosis
was detected only in CHO cells and, to a lesser degree,
in RK13 cells (Table 1). Clearly, host range restriction of
VV, for example in MDBK, CHL, and Don cells, did not
correlate with the induction of apoptosis.
While nucleosomal laddering was easily observed in
CHO cells, a large percentage of the cellular DNA re-
TABLE 1
Vaccinia Virus Induction of Apoptosis in Various Cell Lines
Cells Origin Growtha Apoptosisb
HeLa Human cervix 111 No
CV-1 Monkey kidney 111 No
BS-C-1 Monkey kidney 111 No
CHO Chinese hamster ovary 2 Yes
Dede Chinese hamster lung 111 No
Don Chinese hamster lung 1 No
CHL Chinese hamster lung 2 No
BHK-21 Syrian hamster kidney 111 No
RK13 Rabbit kidney 111 Yes
RAB9 Rabbit skin 1 No
CRFK Feline kidney 1 No
MDBK Bovine kidney 2 No
PK15 Porcine kidney 111 No
a Virus titer at 24 hpi; (1) 10-fold increase; (111) 50- to 100-fold
increase; (2) no increase or decrease.
b Laddering assay performed at 24 hpi.
FIG. 1. Induction of apoptosis by vaccinia virus host range mutants.
CHO, BS-C-1, and RK13 cells were incubated with [125I]deoxyuridine for
24 h to label cellular DNA. The cells were then infected with recombi-
nant VV that contain different combinations of the CHO hr and K1L host
range genes at a multiplicity of 30 PFU/cell. At 24 hpi, the cells were
lysed, total cellular DNA was isolated, and electrophoretic analysis of
nucleosomal cleavage was conducted. Autoradiographs of the dried
gels are shown. U, uninfected; 1, vK1L1CP772; 2, vK1L1CP771; 3,
vK1L2CP772; and 4, vK1L2CP771.
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mained high molecular weight. This could be the result
of a modest degree of apoptosis in all of the cells or
extensive apoptosis in a subpopulation of cells. To ad-
dress this question, we employed an in situ TUNEL
assay to monitor apoptosis in individual cells. When
uninfected CHO cells were mock-infected, no detectable
apoptosis occurred (Fig. 2A). When CHO cells were in-
fected with either the replication-deficient CP772 (Fig.
2B) or replication-competent CP771 recombinant viruses
(Fig. 2C), however, strongly stained cells with character-
istic apoptotic morphology were visible. In either BS-C-1
or RK13 cells, the in situ TUNEL assay failed to detect
apoptotic cells (data not shown).
Although our experiments were done at a multiplicity
of 30 PFU/cell, conditions under which all the cells
should be infected, only 10 to 20% of the cells were
positive by the TUNEL assay. This is probably a minimal
number since apoptotic cells may have been detached
from the slides. We used a b-gal assay to monitor ex-
pression of a late promoter-regulated lacZ gene in CHO
cells infected with vK1L1CP771. b-Gal expression in
nearly all of the cells was easily visualized (Fig. 2D),
showing that apoptosis had occurred in a subpopulation
of infected cells. Infection of all cells with CP772 or
CP771 viruses was also demonstrated with anti-VV an-
tibody (data not shown).
FACS analysis of infected cells that had been sub-
jected to a fluorescent TUNEL assay allows accurate
quantitation of the percentage of apoptotic cells. The
subpopulations of CHO cells that underwent VV-induced
apoptosis were 34.1 and 38.2% in cells infected with
CP772 or CP771 viruses, respectively (Figs. 3A–3C). By
contrast, less than 5% of BS-C-1 cells appeared apoptotic
(Figs. 3D–3F).
To determine the time of the onset of apoptosis, CHO
cells were infected with CP772 or CP771 viruses and
nucleosomal laddering was monitored at various times
(Fig. 4A). In cells infected with CP772 virus, nucleosomal
fragments were clearly observed by 6 hpi. With CP771
virus, laddering was observed at 9 hpi, indicating that the
CHO hr gene delayed the onset of apoptosis.
VV-induced apoptosis occurs in CHO cells in the
absence of viral DNA replication
Infection of CHO cells with VV that lack the CHO hr
gene results in an abrupt cessation of both cellular and
viral protein synthesis (Drillien et al., 1978). The block in
viral protein synthesis occurs after early gene expres-
sion and DNA replication, at the stage of translation of
intermediate mRNAs (Ramsey-Ewing and Moss, 1995).
To determine whether DNA replication was required for
induction of apoptosis, we first prelabeled cellular DNA
with [125I]deoxyuridine. The cells were then treated with
the DNA synthesis inhibitor AraC for 50 min and infected
with CP772 or CP771 viruses in the continued presence
of the drug. At various times postinfection, cells were
harvested and total cellular DNA was isolated and elec-
trophoretically resolved (Fig. 4B). Control experiments
indicated that apoptosis did not occur in uninfected cells
treated with AraC. In contrast, apoptosis occurred in the
presence of AraC when CHO cells were infected. In
addition, inhibition of viral DNA replication did not influ-
ence the onset of nucleosomal laddering. Because both
viral intermediate and late gene expression require DNA
replication, these results suggested that early gene ex-
pression may be sufficient for the induction of apoptosis.
VV-induced apoptosis in CHO cells is independent of
viral or cellular protein synthesis
Under abortive conditions, nonselective shutoff of pro-
tein synthesis occurs after a brief period of cellular and
viral early protein synthesis. To specifically address
whether cellular or viral early protein synthesis was
required for induction of apoptosis in CHO cells, we
compared the ability of wild-type WR and a mutant virus,
vRAP94 (Zhang et al., 1994), to induce apoptosis in CHO
cells. In vRAP94, the RNA polymerase-associated protein
(RAP94) gene is under Echerichia coli lacO control and is
IPTG-inducible. Virions produced in the absence of IPTG
are therefore RAP94-deficient. Because RAP94 itself is
required for specific early transcription (Ahn and Moss,
1992) and packaging of other critical proteins such as
RNA polymerase, capping enzyme, and poly(A) polymer-
ase into virions, the absence of RAP94 results in a
drastic reduction in early gene expression (Zhang et al.,
1994). In addition, we used cycloheximide (CHX), a global
protein synthesis inhibitor, to determine if apoptosis that
occurred during abortive infection was an indirect effect
of the cessation of protein synthesis and could therefore
by mimicked by the drug.
Preliminary experiments indicated that CHX did not
induce apoptosis in mock-infected CHO cells. When
CHO cells were infected with increasing amounts of
purified WR or vRAP94 in the presence or the absence of
CHX, nucleosomal laddering occurred (Fig. 5) even
though protein synthesis was drastically reduced as de-
termined by [35S]methionine labeling (Fig. 6). Because
vRAP94 is a defective virus, we used equivalent amounts
of viral particles instead of plaque-forming units in these
experiments. The particle to cell ratios cover a broad
range of m.o.i.s for WR, including m.o.i. 30, at which other
experiments were done. Laddering was observed with
as few as 230 particles per cell (Fig. 5). For WR, this
particle density corresponds to a m.o.i. of 5.
To analyze viral early protein synthesis, we subjected
cell lysates to immunoprecipitation with anti-VV anti-
serum (Fig. 6). Several VV early proteins were detected in
CHO cells infected with WR, whereas they were only
detected at the highest particle/cell ratios of vRAP94 due
to incomplete repression (Zhang et al., 1994). As ex-
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pected, CHX inhibited viral early protein synthesis. Thus
induction of apoptosis in CHO cells occurred in the
absence of viral early protein synthesis.
Psoralen/UV-inactivated VV particles induce apoptosis
Psoralen/UV treatment results in the introduction of
crosslinks into the viral genome, thereby inactivating
viruses by inhibition of transcription and DNA replication
(Redfield et al., 1981; Hanson, 1992; Tsung et al., 1996).
We exposed vK1L1CP772 virus to long-wave UV light for
increasing amounts of time in the presence of different
amounts of psoralen. One aliquot of virus was immedi-
ately plaque-titered on permissive BS-C-1 cells (data not
shown). Additional aliquots were used to infect CHO
cells to measure nucleosomal laddering (Fig. 7A) and
expression of an early promoter-regulated CAT gene
(Fig. 7B). The results showed that apoptosis occurred,
even at doses of psoralen/UV that decreased infectious
titers by up to 7 logs and reduced CAT activity to less
than 5% of the level in cells infected with untreated
virions.
Antibody to L1R blocks induction of apoptosis
Thus far we have demonstrated that viral gene expres-
sion, specifically early transcription and protein synthe-
sis, is not required for induction of apoptosis in CHO
cells. To establish whether earlier events in the virus life
cycle are required to induce apoptosis, we used mono-
clonal antibody 2D5, which has been reported to inhibit
the penetration of virions into cells (Ichihashi et al., 1994;
Ichihashi and Oie, 1996). This monoclonal antibody binds
to the L1R protein, which is located on the surface of
intracellular mature virions (Wolffe et al., 1995).
We incubated vK1L1CP772 with serial dilutions of
monoclonal antibody 2D5 at 37°C for 30 min. The sam-
ples were divided into two aliquots; one was plaque-
titered on BS-C-1 cells and the other was used to infect
CHO cells. At 24 h postinfection, we measured nucleo-
somal laddering (Fig. 8A) and early gene expression (Fig.
8B). The results show that when the virus was incubated
with neutralizing amounts of monoclonal 2D5, early gene
expression as measured by CAT activity was reduced by
more than 98% (Fig. 8B) and nucleosomal laddering was
FIG. 4. Effect of inhibition of viral DNA replication on apoptosis in
CHO cells. CHO cells were incubated with [125I]deoxyuridine for 24 h to
label cellular DNA. The cells were then infected with vK1L1CP772 or
vK1L1CP771 recombinant VV at a multiplicity of 30 PFU/cell in the
absence (A) or the presence (B) of AraC (40 mg/ml). At the indicated
times postinfection, the cells were lysed, total cellular DNA was iso-
lated, and electrophoretic analysis of nucleosomal cleavage was con-
ducted. Autoradiographs of the dried gels are shown. M, molecular
weight marker; CP772, vK1L1CP772; CP771, vK1L1CP771. Time
(hours) postinfection is indicated above each lane.
FIG. 3. Quantitation of apoptotic population of VV-infected CHO cells.
CHO (A–C) or BS-C-1 (D–F) cells were seeded in T25 flasks and
infected with vK1L1CP772 or vK1L1CP771 recombinant VV at a mul-
tiplicity of 30 PFU/cell. At 24 hpi, the cells were processed for a
fluorescent-TUNEL assay as described under Materials and Methods.
Shown are histograms generated by FACS analysis. A and D, unin-
fected; B and E, vK1L1CP772; C and F, vK1L1CP771. R2–R9 refer to
regions selected for statistical analysis. FL1-H indicates fluorescence
intensity; counts refers to the number of events.
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inhibited (Fig. 8A). Thus VV binding and entry steps are
necessary for induction of apoptosis in CHO cells.
To determine if the critical step for induction of apop-
tosis occurs after virus binding, we incubated CHO cells
with purified vK1L1CP771 at 4°C for 1 h to allow virus
binding. We removed unbound virus by washing three
times with ice-cold medium, then added various dilutions
of monoclonal antibody 2D5, and incubated at 4°C for an
additional 15 min before shifting the infected cells to
37°C. At 24 h postinfection, we measured nucleosomal
laddering (Fig. 9A) and late gene expression (Fig. 9B).
The results show that antibody 2D5 can inhibit both
nucleosomal laddering and late gene expression after
virus binding has occurred, implicating postattachment
events as the trigger(s) for apoptosis in CHO cells.
DISCUSSION
VV is a highly cytopathic virus and productive infec-
tions lead to loss of cell viability (reviewed in Bablanian,
1979). In most cases, however, the cause of cell death is
not understood. Ink et al. (1995) reported that the Copen-
hagen strain of VV induces apoptosis in CHO cells and
that the CP77 host range gene (also called CHO hr)
greatly delays but does not entirely prevent this from
occurring. We had independently noted that the WR
strain of VV induced apoptosis during a study of host
range restriction in CHO cells (Ramsey-Ewing and Moss,
1995), but had not commented on it because fewer than
30% of the cells were so affected by 24 h and apoptosis
appeared to be independent of the presence of CP77, the
host range gene. Moreover, cell viability, as measured by
trypan blue exclusion, was much lower in the presence
of CP77 than in its absence (Ramsey-Ewing and Moss,
1996). A similar phenomenon was noted with regard to
cell viability and K1L gene-mediated suppression of host
range restriction in RK13 cells (Ramsey-Ewing and Moss,
1996). After reading the Ink et al. (1995) paper, we more
carefully compared the kinetics of apoptosis induced by
CP771 and CP772 WR strain viruses. As reported here,
using a sensitive DNA fragmentation assay, we found
evidence of apoptosis within 6 h after infection with
CP772 virus and within 9 h with CP771 virus. Although
the delay mediated by CP77 expression was only 3 h or
less, it was highly reproducible. Thus, the essential find-
ings regarding VV-mediated apoptosis in CHO cells un-
der permissive and nonpermissive conditions were ob-
tained in two laboratories, even though the kinetics of
DNA fragmentation appeared to differ, perhaps due to
use of different virus strains, multiplicities of infection, or
assays.
Our further studies indicated that apoptosis was not
induced or was induced to a lower level by VV in other
nonpermissive or permissive cell lines. There seemed to
be no direct connection between host range restriction
and apoptosis, since the CP77 gene could overcome the
nonpermissive character of two Chinese hamster lung
cell lines (CHL and Don, Ramsey-Ewing, unpublished),
but neither wild-type nor CP77-expressing VV-induced
apoptosis in these cell lines. Moreover, Ink et al. (1995)
demonstrated that the adenovirus E1B-19K protein could
prevent VV-induced apoptosis in CHO cells without re-
lieving the host range restriction.
Early studies had shown that there is a rapid shut-
down of viral and host protein synthesis in CHO cells
infected with wild-type VV, which was subsequently
shown to lack a functional CP77 gene (Drillien et al.,
1978; Hruby et al., 1980; Spehner et al., 1988). More
detailed analyses indicated that the defect occurred at
the time of translation of the intermediate class of viral
mRNAs (Ramsey-Ewing and Moss, 1995). Since VV en-
codes several known antiapoptotic proteins and likely
encodes others yet to be discovered, we favor the idea
that the antiapoptotic effect of CP77 is indirect and me-
diated by enhancing the synthesis of other viral proteins.
Why CHO cells are uniquely sensitive to VV-induced
apoptosis and why VV-encoded antiapoptotic genes are
FIG. 5. Effect of inhibition of viral and cellular protein synthesis on
apoptosis of CHO cells. CHO cells were incubated with [125I]deoxyuri-
dine for 24 h to label cellular DNA. The cells were then infected with
purified WR or vRAP94 at increasing particle/cell ratios in the absence
(top) or the presence (bottom) of cycloheximide (100 mg/ml). At 24 hpi
the cells were lysed, total cellular DNA was isolated, and electro-
phoretic analysis of nucleosomal cleavage was conducted. An autora-
diograph of the dried gel is shown. CHX, cycloheximide; WR, vaccinia
strain WR; vRAP94, WR with IPTG-inducible RAP94 grown in the ab-
sence of IPTG. Lanes 1 and 7, uninfected cells; lanes 2 and 8, 45
particles/cell; lanes 3 and 9, 113 particles/cell; lanes 4 and 10, 233
particles/cell; lanes 5 and 11, 450 particles/cell; and lanes 6 and 12,
2330 particles/cell.
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ultimately ineffective in blocking apoptosis are not un-
derstood.
The fact that only a fraction of infected CHO cells
underwent apoptosis as measured by the TUNEL assay,
even though all of the cells were infected, was puzzling.
We considered two possible explanations. The first is
that VV-induced apoptosis is cell cycle-dependent, as
recently observed for bovine herpesvirus 1 (Hanon et al.,
1997). To examine this, CHO cells were synchronized
and G0, S, and M/G2 populations were infected with VV.
However, VV induced apoptosis to similar extents in
each cell population (data not shown). Next, we consid-
ered that CHO cells might be genetically heterogeneous,
consisting of mixtures of susceptible and nonsusceptible
lineages. To evaluate this possibility, CHO cell lines were
cloned by limiting dilution. However, when clones were
infected, similar fractions of the population suffered
apoptosis (data not shown). Therefore, the tendency to
undergo apoptosis appeared to be neither cell cycle- nor
lineage-dependent.
The main thrust of the present study was to investigate
the events required to induce apoptosis, a subject much
less well studied than viral antiapoptotic genes. Since
wild-type VV was able to induce apoptosis in CHO cells,
we knew that neither viral intermediate nor late protein
synthesis were necessary. Genome replication was also
not required as apoptosis occurred in the presence of a
DNA synthesis inhibitor. The latter result was consistent
with a recent report of VV-induced apoptosis in a CHO
mutant cell line that prevents VV DNA replication from
occurring (Bair et al., 1996). Next, we determined that
viral early protein synthesis was not needed, because
apoptosis occurred in the presence of cycloheximide.
Finally, we demonstrated that viral early mRNA synthesis
was not required using both a recombinant VV that has
the gene encoding the RNA polymerase-associated pro-
FIG. 6. Analysis of viral and cellular protein synthesis. CHO cells were infected with purified WR or vRAP94 at increasing particle/cell ratios in the
absence (top) or the presence (bottom) of cycloheximide (100 mg/ml). At 2 hpi the cells were metabolically labeled with [35S]methionine for 1 h. The
cells were then lysed in NP-40 buffer and the lysate was centrifuged to pellet nuclei. Either total 35S-labeled proteins were resolved by SDS–PAGE
or lysates were subjected to immunoprecipitation with anti-VV antiserum as described under Materials and Methods. Autoradiographs of the dried
gels are shown. CHX, cycloheximide; M, molecular weight marker; TOTAL, total labeled proteins; anti-VV, immunoprecipitated proteins. Samples
numbered as in Fig. 5 from WR-infected cells (lanes 1–6) and from vRAP94-infected cells (lanes 7–12). Arrows indicate viral early proteins.
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tein of 94 kDa (RAP94) repressed and by crosslinking
viral genomic DNA with UV light and psoralen. Indeed,
apoptosis was blocked only when virus was treated with
a neutralizing monoclonal antibody to the L1R protein,
which inhibits the penetration phase of virus entry (Ichi-
hashi and Oie, 1996; Wolffe et al., 1995). Further, we
demonstrated that monoclonal 2D5 can inhibit induction
of apoptosis after virus binding has occurred at 4°C,
consistent with reports that this antibody inhibits at a
postattachment step. The experiments we report here do
not discriminate between different postattachment steps
such as receptor signaling or virus internalization. The
cellular protein that interacts with L1R, however, is not
known. One candidate cell surface receptor has been
identified, but the viral protein that it interacts with has
not been determined (Chang et al., 1995b). The possibil-
ity exists that there are several cellular receptors for VV
(Vanderplasschen and Smith, 1997).
Precedents exist for the induction of apoptosis via cell
surface protein–protein interactions in both viral and
nonviral systems. Examples of the former include bind-
ing of HIV-1 gp120 to cell surface CD4 (Banda et al., 1992;
Laurent-Crawford et al., 1995) and binding of inactivated
bovine herpesvirus 1 to peripheral blood mononuclear
cells (Hanon et al., 1996); examples of the latter include
T-cell-receptor-mediated activation of apoptosis and
binding of antibodies to cell surface APO-1 and Fas
(Green and Scott, 1994). In principal, the interaction of VV
particles with one of its receptors might trigger an intra-
cellular apoptosis signaling pathway.
MATERIALS AND METHODS
Cells and viruses
BS-C-1 (kidney, African green monkey, ATCC CCL 26)
and HeLa (cervix, human, ATCC CCL 2.2) monolayer cells
were grown in minimum essential medium (MEM) sup-
plemented with 2.5% fetal calf serum (FCS). RK13 (kidney,
rabbit, ATCC CCL 37), MDBK (kidney, bovine, ATCC CCL
22), RAB-9 (skin, rabbit, ATCC CRL 1414), and CRFK
(kidney, feline, ATCC CCL 94) cells were grown in MEM
supplemented with 10% FCS. CV-1 (kidney, African green
monkey, ATCC CCL 70) cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) in the presence of 10%
FCS. CHO (ovary, Chinese hamster, ATCC CCL 61) and
CHL (lung, Chinese hamster, ATCC CRL 1935) cells were
grown in Ham’s F-12 medium supplemented with 5%
FCS. Dede (ATCC CCL 39) and Don (ATCC CCL 16)
Chinese hamster lung cells were grown in McCoy’s 5A
medium supplemented with 20% FCS.
VV strain WR and recombinants thereof were propa-
gated as described (Earl et al., 1991). Briefly, crude virus
preparations consisted of lysates from infected HeLa S3
cells prepared 3 days postinfection by freeze–thawing
and sonication. Titers of such crude preparations were
between 2 and 6 3 109 PFU/ml. For purified virus prep-
arations, sonicated cell lysates were layered onto su-
crose cushions, pelleted, and then subjected to two
rounds of sucrose gradient banding. Titers of purified
virus preparations were between 2 and 6.5 3 1010 PFU/
ml. The set of host range mutants, which includes recom-
binant viruses vK1L1CP772, vK1L1CP771, vK1L2CP772,
and vK1L2CP771, has been described elsewhere (Ram-
sey-Ewing and Moss, 1996). All of these viruses contain
a dual reporter cassette at the tk locus in which the
chloramphenicol acetyltransferase (CAT) gene is regu-
lated by a viral early promoter (VGF) and the lacZ gene is
regulated by a viral late promoter (11K). In addition,
recombinant viruses vK1L1CP772 and vK1L1CP771
contain the K1L host range gene, while recombinants
vK1L1CP771 and vK1L2CP771 carry the cowpox virus
CHO hr gene, also referred to as CP77; recombinant
vK1L2CP772 lacks both host range genes. The VV mu-
tant vRAP94 (Zhang et al., 1994) has the wild-type RNA
FIG. 7. Effect of psoralen/UV inactivation on induction of apoptosis
and early gene expression. (A) CHO cells were incubated with
[125I]deoxyuridine for 24 h to label cellular DNA. The cells were then
infected with vK1L1CP772 that had been inactivated in the presence of
the indicated amounts of psoralen for the indicated periods of time. At
24 hpi the cells were lysed, total cellular DNA was isolated, and
electrophoretic analysis of nucleosomal cleavage was conducted. An
autoradiograph of the dried gel is shown. 0, 1, and 5 mg/ml refer to the
concentration of psoralen. 0, 2, 4, and 6 min refer to time of UV
exposure. (B) CAT activity was determined in lysates prepared from
cells at 24 h after infection with psoralen/UV treated vK1L1CP772. CAT
activity was measured by a liquid scintillation counting method. The bar
graph shows levels of CAT activity, expressed as thousands of counts
per minute, vs psoralen concentration at each UV dose.
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polymerase-associated protein (RAP94) gene replaced
with an isopropylthio-b-galactoside (IPTG)-inducible copy.
Psoralen/UV virus inactivation
VV in 1 ml of Ham’s F-12 medium containing 0, 1, or 5
mg/ml psoralen (trioxsalen, 49-aminomethyl-HCl, Calbio-
chem) was placed in 1 well of a 12-well dish and ex-
posed at room temperature for varying lengths of time to
long-wave UV light (365 nm) emanating from a BLACK-
RAY UV lamp (Ultraviolet Products, Inc., San Gabriel, CA)
at a distance of 3 in. Each preparation was then divided
into two portions. One was used to infect CHO cells for
analysis of apoptosis; serial dilutions of the other portion
were titered by counting plaques that had formed in 48 h
on permissive BS-C-1 cells.
Virus neutralization
Monoclonal antibody 2D5 (Ichihashi and Oie, 1994)
was kindly provided by Y. Ichihashi. Purified virus prep-
arations were incubated with serial dilutions of antibody
for 30 min at 37°C as described in Wolffe et al. (1995).
The antibody-treated virus was then divided into two
portions. One was used to infect CHO cells for analysis
of apoptosis; the other was serially diluted and infectious
titers were determined by counting plaques on permis-
sive BS-C-1 cells.
To determine if monoclonal 2D5 blocks virus binding
or subsequent postattachment steps, we first incubated
cells with virus at 4°C for 1 h to allow binding. The cells
were then washed three times with ice-cold medium,
serial dilutions of antibody 2D5 were added, and the
incubation continued at 4°C for 15 min before raising the
temperature to 37°C. At 24 hpi, infected cells were har-
vested.
Analysis of protein synthesis and immunoprecipitation
Confluent CHO monolayers were infected with 30
PFU/cell of recombinant VV. Prior to metabolic labeling,
cells were incubated for 20 to 30 min at 37°C in methi-
onine-free medium (DMEM). At the indicated time postin-
fection, cells were incubated for 1 h at 37°C in methi-
onine-free DMEM containing 5% dialyzed fetal bovine
serum (GIBCO) in the presence of [35S]methionine (Am-
ersham, 10 mCi/ml, 1175 Ci/mmol) at 300 mCi/ml. The
cells were washed twice with cold phosphate-buffered
saline (PBS) and then incubated at 37°C for 5 min in
hypotonic lysis buffer [20 mM Tris–HCl (pH 8.0), 10 mM
NaCl, 0.5% Nonidet P-40 (NP-40)]. The lysate was centri-
fuged at 12,000 g for 5 min at room temperature to pellet
nuclei, and the supernatants were stored at 220°C. For
sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS–PAGE), a portion of each sample was
mixed with an appropriate volume of SDS/2-mercapto-
ethanol sample buffer, boiled for 5 min, and then re-
solved by electrophoresis in SDS/10% polyacrylamide
gels. For immunoprecipitation, samples were incubated
with rabbit polyclonal antiserum to vaccinia virus at a
1:500 dilution at 4°C overnight. An equal volume of 20%
Protein A–Sepharose beads (Pharmacia) in PBS was
added and incubation continued at room temperature for
an additional 3 h. Immune complexes were washed
twice in Triton buffer [300 mM NaCl, 50 mM Tris–HCl (pH
7.4), 0.1% Triton-X-100], recovered by boiling in sample
FIG. 8. Effect of neutralizing antibody to the virion L1R protein on early gene expression and apoptosis. (A) CHO cells were incubated with
[125I]deoxyuridine for 24 h to label cellular DNA. The cells were then infected with vK1L1CP772 that had been incubated with serial dilutions of
monoclonal antibody 2D5 for 30 min at 37°C. At 24 hpi the cells were lysed, total cellular DNA was isolated, and electrophoretic analysis of
nucleosomal cleavage was conducted. An autoradiograph of the dried gel is shown. Lanes 1–5, decreasing concentrations of anti-L1R antibody; lane
6, no antibody. (B) CAT activity was determined in lysates prepared from cells at 24 h after infection with vK1L1CP772 that had been incubated with
serial dilutions of monoclonal antibody 2D5. CAT activity was measured by a liquid scintillation counting method. The bar graph shows levels of CAT
activity, expressed as thousands of counts per minute (cpm), vs antibody dilution; none, infection with virus that had not been preincubated with
antibody.
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buffer, and then resolved in SDS/12% polyacrylamide
gels.
Analysis of reporter gene expression
Cells were infected with recombinant viruses at mul-
tiplicities of 30 PFU/cell. At 24 h postinfection, the cells
were washed twice with room temperature PBS and then
processed for analysis of CAT or b-galactosidase (b-gal)
enzyme activities.
For CAT activity determinations, cells were incubated
for 15 min at 37°C in 13 reporter lysis buffer (500 ml/5 3
105 cells) (Promega). The lysates were then subjected to
a liquid scintillation counting CAT assay as described by
the manufacturer. Briefly, reactions containing 10 ml of a
1:10 dilution of each sample, 10 ml of [14C]chlorampheni-
col (Amersham, 25 mCi/ml, 55 mCi/mmol), 10 ml of 4
mg/ml n-butyryl coenzyme A (Sigma), and 90 ml 0.25 M
Tris–HCl (pH 8.0), were incubated overnight at 37°C. The
butyrylated chloramphenicol products were extracted
with mixed xylenes and an aliquot was counted in a
Beckman LS5000 TD liquid scintillation counter.
For in situ analysis of b-gal expression, washed cell
monolayers that had been seeded on multichamber
slides (Labtek) were fixed in 1% gluteraldehyde in 0.1 M
sodium phosphate (pH 7.0) and 1 mM magnesium chlo-
ride for 15 min at room temperature. An equal volume of
23 assay buffer [0.2% 5-bromo-4-chloro-3-indolyl-b-D-ga-
lactosidase (X-Gal) in 10 mM sodium phosphate (pH 7.0),
1 mM magnesium chloride, 150 mM sodium chloride, 3.3
mM potassium ferricyanide, 3.3 mM potassium ferricya-
nide trihydrate] was added and the slides were incu-
bated an additional 16 h at 37°C.
For quantitative analysis of b-gal expression, infected
cells were washed twice with PBS and then incubated
for 15 min at 37°C in 13 reporter lysis buffer (500 ml/5 3
105 cells) (Promega). The lysates were centrifuged to
remove debris and then mixed with an equal volume of
23 assay buffer (Promega). Enzymatic reactions in
100-ml volumes were conducted for 30 min at 37°C, and
substrate conversion was determined by spectropho-
tometry.
DNA fragmentation assay
Cells were seeded in regular medium and allowed to
reach approximately 50% confluence. The medium was
then replaced with medium containing 0.5 mCi/ml
[125I]deoxyuridine (Amersham, 1 mCi/ml, 2000 Ci/mmol).
After 16–24 h the cells were washed three times, incu-
bated for 1 h in regular medium, and then infected with
recombinant VV at a multiplicity of 30 PFU/cell. After 24 h,
the medium was aspirated and the cells were washed
twice with PBS. Cells were lysed in SDS buffer (500
ml/5 3 105 cells) containing 100 mM NaCl, 10 mM Tris–
HCl (pH 8.0), 25 mM EDTA (pH 8.0), 0.5% sodium dodecyl
sulfate (SDS), and fresh proteinase K added to 0.1 mg/ml
and incubated overnight at 37°C. Cell lysates were ex-
tracted twice with phenol/chloroform and then ethanol
precipitated. Aliquots of each sample were resolved on
1.5% agarose/TBE gels, which were dried at 55°C and
then exposed to X-O-Mat or Biomax X-ray film for 24 to
48 h.
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end-labeling (TUNEL) assay
For in situ TUNEL assays, cells were seeded on mul-
tichamber slides (Labtek) 24 h prior to infection with 30
PFU/cell of recombinant viruses. At 24 h postinfection,
the cells were washed twice with PBS, fixed with 4%
paraformaldehyde for 15 min at room temperature,
FIG. 9. Postattachment effects of neutralizing monoclonal antibody
on late gene expression and apoptosis. (A) CHO cells were incubated
with [125I]deoxyuridine for 24 h to label cellular DNA. The cells were
then infected with vK1L1CP771 and incubated at 4°C for 1 h. Excess
virus was removed by washing, and the infected cells were incubated
with serial dilutions of monoclonal antibody 2D5 for 15 min at 4°C and
then shifted to 37°C. At 24 hpi the cells were lysed, total cellular DNA
was isolated, and electrophoretic analysis of nucleosomal cleavage
was conducted. An autoradiograph of the dried gel is shown. Lane 1, no
antibody; lanes 2–5, decreasing concentrations of anti-L1R antibody.
(B) b-Gal activity was determined in lysates prepared at 24 hpi from
cells infected as described above. The bar graph shows levels of b-gal
activity, expressed as the percentage of activity measured in untreated
infected cells, vs antibody dilution; none, no antibody was used.
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washed three times with PBS, and then permeabilized
with PBS containing 1% Triton-X-100 and 0.1% sodium
citrate for 2 min on ice. After several washes in PBS, the
cells were incubated with the TUNEL reaction mixture as
specified by the manufacturer (Oncor). Briefly, cells were
exposed to digoxigenin-labeled dUTP in the presence of
terminal deoxynucleotidyltransferase (Tdt) for 1 h fol-
lowed by peroxidase-conjugated anti-digoxigenin anti-
body for 30 min. Color development proceeded for 15 min
after introduction of the substrate.
For flow cytometric analysis, cells were seeded in T25
flasks and infected 24 h later with recombinant viruses at
a multiplicity of 30 PFU/cell. At 24 h postinfection, de-
tached cells were combined with adherent cells that had
been dislodged by scraping in PBS, and the mixture was
centrifuged at 2500 rpm for 5 min. After a second cen-
trifugation at 2500 rpm for 5 min, the cell pellets were
resuspended in 4% paraformaldehyde and incubated for
15 min at room temperature with intermittent gentle
shaking. The fixed cells were washed three times in PBS
and then incubated with TUNEL reaction mixture con-
taining fluoroscein-conjugated dUTP as specified by the
manufacturer (Boehringer-Mannheim). After the 1-h la-
beling reaction, cells were washed several times with
PBS and resuspended at approximately 3 to 5 3 105
cells/ml for FACS analysis using a Becton–Dickinson
FACScan machine with CellQuest software.
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